New research identifies a potential characteristic for predicting outcome in a deadly form of brain cancer known as glioblastoma multiforme. Existing therapies based on genetic information have failed to effectively treat glioblastomas. Therefore, researchers are aggressively looking to find new molecular targets for this aggressive brain tumor.